The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 212.00
Bid: 202.00
Ask: 207.00
Change: 18.00 (9.28%)
Spread: 5.00 (2.475%)
Open: 196.00
High: 212.00
Low: 196.00
Prev. Close: 194.00
NXR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealings

19 Jul 2022 13:57

RNS Number : 0145T
Norcros PLC
19 July 2022
 

Norcros plc ("Norcros" or "the Company")

Director Dealings - APSP Share Option and Deferred Share awards

 

Director/PDMR Shareholding

Norcros announces that the Board, following a recommendation from the Remuneration Committee, has granted new share options to the following Directors under the Company's Approved Performance Share Plan (the "APSP") and Deferred Bonus Plan (the "DBP") on 19 July 2022.

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation ("MAR"), provides further detail.

APSP Share Option Awards

The Company has today granted the following unapproved nil cost share option awards under the APSP in respect of the current financial year (the "APSP Awards") to two Executive Directors of the Company over ordinary shares of ten pence each in the Company ("Ordinary Shares"). 

Under the APSP, awards are made subject to performance targets relating to improvements in the Company's Earnings Per Share ("EPS"). Vesting of these Ordinary Shares will be subject to achieving aggregate diluted EPS targets over a three year performance period, starting with the 2023 financial year.

The APSP Awards will normally vest on the third anniversary of their grant, subject to satisfactory achievement of the performance targets. No consideration was paid for the APSP Awards.

Name

Number of Ordinary Shares subject to the APSP Award

Nick Kelsall

218,348

James Eyre

133,027

 

Bonus payment - Deferred Share Awards

Under the annual bonus scheme, 50 per cent. of an Executive Director's total bonus for the year is satisfied in cash, with the other 50 per cent. in the form of nil cost options under the DBP. These options represent 50 per cent. of the bonuses earned by the Executive Directors for the 2022 financial year.

Norcros therefore also announces the grant of the following nil cost share option awards under the DBP in respect of the year ended 31 March 2022 (the "Deferred Awards") to the relevant Executive Director of the Company over Ordinary Shares.

Name

Number of Ordinary Shares subject to the Deferred Bonus Plan Award

Nick Kelsall

James Eyre

89,098

39,894

 

The Deferred Awards will normally vest on the third anniversary of their grant. Because these shares represent part of a bonus already earned, no consideration was paid for the Deferred Awards and no consideration is due to be payable on vesting.

MAR Notification

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nick Kelsall

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Norcros plc

b)

LEI

213800EIMJZZA1GBIE18

4 A

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Share of 10 pence

 

 

GB00BYYJL418

 

b)

 

Nature of the transaction

 

Grant of 218,348 options under the Company's Approved Performance Share Plan (the "APSP") and 89,098

 options under the Deferred Bonus Plan (the "DBP") on 19 July 2022

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

n/a

 

n/a

d)

 

Aggregated information

- Aggregated volume

- Price

 

n/a

n/a

 

e)

 

Date of the transaction

 

19 July 2022

f)

 

Place of the transaction

 

Wilmslow, Cheshire, England

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James Eyre

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Norcros plc

b)

LEI

213800EIMJZZA1GBIE18

4 A

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Share of 10 pence

 

 

GB00BYYJL418

 

b)

 

Nature of the transaction

 

Grant of 133,027 options under the Company's Approved Performance Share Plan (the "APSP") and 39,894 options under the Company's Deferred Bonus Plan (the "DBP") on 19 July 2022

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

n/a

n/a

d)

 

Aggregated information

- Aggregated volume

- Price

 

n/a

n/a

 

e)

 

Date of the transaction

 

19 July 2022

f)

 

Place of the transaction

 

Wilmslow, Cheshire, England

 

 

Further enquiries:

Norcros plc

Tel: 01625 547 700

Nick Kelsall, Chief Executive Officer

James Eyre, Chief Financial Officer

Hudson Sandler

Tel: 0207 796 4133

Nick Lyon

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPUQAMUPPGPB
Date   Source Headline
9th Mar 20214:58 pmRNSDirector Shareholding
3rd Mar 20217:00 amRNSTrading Update
2nd Mar 20215:28 pmRNSTotal Voting Rights
2nd Mar 20214:38 pmRNSHolding(s) in Company
23rd Dec 202012:08 pmRNSEmployee SAYE awards and director shareholding
22nd Dec 20207:00 amRNSVoting Rights and Share Capital Update
8th Dec 20202:57 pmRNSHolding(s) in Company
30th Nov 20204:57 pmRNSVoting Rights and Share Capital Update
23rd Nov 20203:12 pmRNSDirectors' Dealings - APSP Share Option awards
17th Nov 20203:28 pmRNSHolding(s) in Company
16th Nov 20205:17 pmRNSDirectors' Dealings
12th Nov 20207:00 amRNSInterim Results
4th Nov 20205:35 pmRNSHolding(s) in Company
15th Oct 20207:00 amRNSTrading Update
30th Sep 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
25th Aug 20204:36 pmRNSPrice Monitoring Extension
30th Jul 20202:06 pmRNSResults of AGM
30th Jul 20207:00 amRNSAGM Trading Statement
24th Jul 20209:33 amRNSHolding(s) in Company
15th Jul 20204:40 pmRNSSecond Price Monitoring Extn
15th Jul 20204:35 pmRNSPrice Monitoring Extension
6th Jul 202012:35 pmRNSHolding(s) in Company
3rd Jul 20207:00 amRNSAGM & Annual report announcement
25th Jun 20204:41 pmRNSSecond Price Monitoring Extn
25th Jun 20204:35 pmRNSPrice Monitoring Extension
25th Jun 20207:00 amRNSFinal Results
23rd Jun 202010:54 amRNSNotice of Results
22nd Jun 202010:44 amRNSHolding(s) in Company
1st May 20202:41 pmRNSVoting Rights and Share Capital Update
27th Apr 20205:49 pmRNSDirector Declaration
9th Apr 20209:35 amRNSHolding(s) in Company
8th Apr 20207:00 amRNSHolding(s) in Company
3rd Apr 202011:39 amRNSDirector's Shareholdings
3rd Apr 202011:21 amRNSDirector's Shareholding
1st Apr 20207:00 amRNSTrading update
30th Mar 202012:07 pmRNSSecond Price Monitoring Extn
30th Mar 202012:02 pmRNSPrice Monitoring Extension
25th Mar 202011:37 amRNSVoting Rights and Share Capital Update
11th Mar 20204:35 pmRNSPrice Monitoring Extension
11th Mar 20202:10 pmRNSDirector's Shareholding
11th Mar 20207:00 amRNSDirectorate Changes
10th Mar 202010:54 amRNSDirectors' Shareholdings
2nd Mar 20202:43 pmRNSBlock Listing Six Monthly Return
27th Feb 202011:52 amRNSBlock Listing Application
20th Feb 20207:00 amRNSTrading update and impact of the Coronavirus
20th Feb 20207:00 amRNSTrading update and impact of the Coronavirus
4th Feb 20205:11 pmRNSHolding(s) in Company
31st Jan 20207:00 amRNSVoting Rights and Share Capital Update
10th Jan 20205:32 pmRNSDirectors' Dealings
13th Dec 20194:23 pmRNSEmployee SAYE awards and director shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.